Partner portal 
19001717 NIPT 3 is an upgrade choice of the Non-Invasive Prenatal Testing Panel and includes screening for Turner Syndrome (Monosomy X or XO). This condition is identified by the presence of a single X chromosome in females instead of the usual two (XX). NIPT 3 analyzes fetal DNA in the mother's blood to detect Turner Syndrome and other chromosomal abnormalities early in the pregnancy. By identifying potential conditions such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and Turner Syndrome, NIPT 3 offers comprehensive insight into the fetus's chromosomal health. This early detection is crucial for planning medical management and counseling for expectant parents, providing valuable information about their baby's health and any potential genetic conditions.
